In multiple myeloma (MM), piRNA-823 directly recruited de novo DNA methyltransferases DNMT3A and DNMT3B in primary CD138+ MM cells, increasing global DNA methylation and inhibiting tumor suppressor p16INK4A expression [36]. The gene discussed is CDKN2A; the disease is Miyoshi myopathy.